For patients with iliac artery blockages, treatment with a self-expanding stent provides better protection against restenosis at 12 months and no reduction in safety compared with a balloon-expandable ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Self-expanding and balloon-expandable stents were equally safe and effective in patients with iliac ...

VISIBILITY Iliac and DURABILITY Iliac Studies Evaluate the Safety and Effectiveness of Balloon Expandable and Self-Expanding Stents in Treating Iliac Artery Disease Each study is designed to evaluate ...

Please provide your email address to receive an email when new articles are posted on . Results of the MOBILITY trial suggest that a self-expanding stent system and a balloon-expandable stent system ...

DUBLIN -- Medtronic plc today announced that its Protégé(TM) GPS(TM) self-expanding peripheral stent system has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of ...

-- Approval Based on Positive Clinical Evidence From the MOBILITY Study, Involving Real-World Patients with Complex Disease "The MOBILITY study demonstrated that treatment with Omnilink Elite resulted ...

With the introduction of self-expanding stents, an increased number of complex diseases were treated, with success rates comparable to those of open surgery. [14,15] In a contemporary study, the use ...

LAS VEGAS--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex™ stent at the Vascular ...

ABBOTT PARK, Ill., Aug. 7, 2012 /PRNewswire/ -- Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite ® Vascular Balloon-Expandable Stent System for the ...